1-3 of 3
vascular access-associated thromboembolism
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results From the Phase 2 Continuation Study of the Lenalidomide and Azacitidine Combination in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Mikkael A. Sekeres, MD, MS, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Ramon V. Tiu, MD, Anjali S. Advani, MD, Manual Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, M.S., Jennifer Paleveda, Ronald Paquette, MD, PhD, April Smith, Lori Strozniak, Alan F. List, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 607.
https://doi.org/10.1182/blood.V118.21.607.607
Published: 2011
Journal Articles

High Prevalence of Antibodies to the Heparin-Platelet Factor 4 Complex in Hemodialysis Patients.

Marc Carrier, MD, Greg Knoll, MD, Michael Kovacs, MD, Marc A. Rodger, MD
Journal: Blood
Blood (2005) 106 (11): 4119.
https://doi.org/10.1182/blood.V106.11.4119.4119
Published: 2005
Journal Articles

Recurrent Vascular Access Site Thrombosis in Patients on Hemodialysis - a Problem of Thrombophilia?.

Robert Klamroth, MD, Frank Seibt, MD, Hartmut Rimpler, MD, Helmut Landgraf, MD
Journal: Blood
Blood (2004) 104 (11): 4018.
https://doi.org/10.1182/blood.V104.11.4018.4018
Published: 2004